Aglaia Oncology Funds, an investment fund fully focused on the fight against cancer and the development of improved anti-cancer drugs in particular. Aglaia has a proven ability to select and mature early-stage breakthrough inventions that have the potential to transform cancer treatment.
Aglaia is looking for excellent cancer research with the potential to be translated into cancer medicines. This translates specifically in:
– Early-stage oncology drug development
– Disruptive science with the potential to transform cancer diagnosis and therapy
– Spread across different drug modalities (small molecules, biologicals, etc.) and drug development phases (from target discovery up to clinical development)